West Pharmaceutical Services Inc (WST)
314.77
-1.73
(-0.55%)
USD |
NYSE |
Nov 04, 16:00
316.20
+1.43
(+0.45%)
After-Hours: 20:00
West Pharmaceutical Services Net Income (Quarterly): 136.00M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 136.00M |
| June 30, 2024 | 111.30M |
| March 31, 2024 | 115.30M |
| December 31, 2023 | 137.00M |
| September 30, 2023 | 161.30M |
| June 30, 2023 | 155.10M |
| March 31, 2023 | 140.00M |
| December 31, 2022 | 103.00M |
| September 30, 2022 | 120.60M |
| June 30, 2022 | 188.50M |
| March 31, 2022 | 173.80M |
| December 31, 2021 | 147.70M |
| September 30, 2021 | 175.60M |
| June 30, 2021 | 187.30M |
| March 31, 2021 | 151.20M |
| December 31, 2020 | 98.40M |
| September 30, 2020 | 82.30M |
| June 30, 2020 | 91.20M |
| March 31, 2020 | 74.30M |
| December 31, 2019 | 63.90M |
| September 30, 2019 | 56.30M |
| June 30, 2019 | 66.10M |
| March 31, 2019 | 55.40M |
| December 31, 2018 | 52.00M |
| September 30, 2018 | 55.20M |
| Date | Value |
|---|---|
| June 30, 2018 | 56.10M |
| March 31, 2018 | 43.60M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 51.00M |
| June 30, 2017 | 38.80M |
| March 31, 2017 | 60.90M |
| December 31, 2016 | 39.10M |
| September 30, 2016 | 37.60M |
| June 30, 2016 | 44.70M |
| March 31, 2016 | 22.10M |
| December 31, 2015 | 33.40M |
| September 30, 2015 | 1.50M |
| June 30, 2015 | 27.80M |
| March 31, 2015 | 32.90M |
| December 31, 2014 | 31.40M |
| September 30, 2014 | 31.00M |
| June 30, 2014 | 37.60M |
| March 31, 2014 | 27.10M |
| December 31, 2013 | 23.60M |
| September 30, 2013 | 26.80M |
| June 30, 2013 | 30.20M |
| March 31, 2013 | 31.70M |
| December 31, 2012 | 21.10M |
| September 30, 2012 | 14.80M |
| June 30, 2012 | 15.60M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
63.90M
Minimum
Dec 2019
188.50M
Maximum
Jun 2022
130.69M
Average
136.50M
Median
Net Income (Quarterly) Benchmarks
| Repligen Corp | 3.321M |
| Perspective Therapeutics Inc | -11.70M |
| Retractable Technologies Inc | -14.16M |
| Xtant Medical Holdings Inc | -3.861M |
| Catheter Precision Inc | -4.22M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 746.90M |
| Total Expenses (Quarterly) | 581.20M |
| EPS Diluted (Quarterly) | 1.85 |
| Enterprise Value | 22.63B |
| Gross Profit Margin (Quarterly) | 35.44% |
| Profit Margin (Quarterly) | 18.21% |
| Earnings Yield | 2.14% |
| Operating Earnings Yield | 2.54% |
| Normalized Earnings Yield | 2.208 |